Upcoming Webinars
-
FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
In this webinar, Denise Holliday, Expert Witness at Capwell Consulting Group, helps you understand how the transition to QMSR may affect regulatory compliance, product liability exposure, and organizational risk.
Register for FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry Read More about FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
Past Webinars
-
Clinical Trials in The Era of COVID-19
This session presenters, Dianne Bourque and Benjamin Zegarelli from Mintz, will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research...
Read More about Clinical Trials in The Era of COVID-19 -
Mitigating Product Liability Risk in the Era of COVID-19
The following topics will be covered in this webinar: Outlining potential product liability risk involving COVID (defect claims involving marketing/advertising, warranties, and warnings) Tips on...
Read More about Mitigating Product Liability Risk in the Era of COVID-19 -
Force Majeure: COVID-19
This session we look at force-majeure clauses and how this frequently overlooked contractual language can be utilized should the pandemic interrupt your life sciences business operations.
Read More about As the country responds to the COVID-19 pandemic, life sciences companies as well as manufacturers that do not normally produce medical devices are coming together to fill the vast gaps in... -
Public Readiness and Emergency Preparedness Act (PREP Act)
As the country responds to the COVID-19 pandemic, life sciences companies as well as manufacturers that do not normally produce medical devices are coming together to fill the vast gaps in...
Read More about Public Readiness and Emergency Preparedness Act (PREP Act)